Vertical Peak Holdings Inc (SPLIF)
0.004
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Vertical Peak Holdings Revenue (TTM): 6.202M for April 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| April 30, 2023 | 6.202M |
| January 31, 2023 | 5.471M |
| October 31, 2022 | 5.429M |
| July 31, 2022 | 4.918M |
| April 30, 2022 | 3.728M |
| January 31, 2022 | 2.747M |
| October 31, 2021 | |
| July 31, 2021 | |
| April 30, 2021 |
| Date | Value |
|---|---|
| January 31, 2021 | |
| October 31, 2020 | |
| July 31, 2020 | 0.2558M |
| April 30, 2020 | 12.56M |
| January 31, 2020 | 16.27M |
| October 31, 2019 | 18.46M |
| July 31, 2019 | 17.83M |
| April 30, 2019 | 16.77M |
| January 31, 2019 | 13.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.2558M
Minimum
Jul 2020
18.46M
Maximum
Oct 2019
9.220M
Average
5.836M
Median
Revenue (TTM) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.386M |
| Xenon Pharmaceuticals Inc | -- |